Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
<h4>Background</h4>Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patient...
Guardado en:
Autores principales: | Karen Shean, Elizabeth Streicher, Elize Pieterson, Greg Symons, Richard van Zyl Smit, Grant Theron, Rannakoe Lehloenya, Xavier Padanilam, Paul Wilcox, Tommie C Victor, Paul van Helden, Martin P Grobusch, Robin Warren, Motasim Badri, Keertan Dheda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8445b22ee32749ae8d66166770a7d2b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting.
por: Keertan Dheda, et al.
Publicado: (2009) -
Development of multifunctional nanocomposites for controlled drug delivery and hyperthermia
por: Vladimir Hovhannisyan, et al.
Publicado: (2021) -
Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
por: Amy S Nunn, et al.
Publicado: (2007) -
High prevalence of drug resistance in animal trypanosomes without a history of drug exposure.
por: Simbarashe Chitanga, et al.
Publicado: (2011) -
Network neighbors of drug targets contribute to drug side-effect similarity.
por: Lucas Brouwers, et al.
Publicado: (2011)